Navigation Links
STALLERGENES and Protein' eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
Date:12/13/2007

ANTONY, GRENOBLE France, December 13 /PRNewswire-FirstCall/ -- STALLERGENES S.A and Protein'eXpert S.A. announce they have signed a partnership agreement for developing and pharmaceutically producing mites recombinant allergens(1).

The partnership is part of the STALLERGENES "Enhanced Allergens" innovation programme for a recombinant protein treatment for sublingual desensitisation of allergy to mites. This second-generation treatment is made up of the recombinant allergens Der p 1 and Der p 2 in the form of a fusion protein, combined with an adjuvant and/or a mucoadhesive formulation for facilitating recognition of the allergen by the immune system.

Protein'eXpert will handle:

- developing processes aimed at optimising the existing production protocol;

- developing and scaling up fermentation, renaturation, and purification processes;

- producing preclinical and clinical batches.

"This partnership enables us to accelerate the development of our "Enhanced Allergens" programme, and to envisage moving rapidly on to humans in a phase I study," emphasizes Philippe Moingeon, Scientific Director of STALLERGENES. Protein'eXpert has indeed recognised know-how in the field of process development and cGMP(2) biomanufacturing."

"Protein'eXpert is very pleased to be taking part in an innovative development programme in the specific field of respiratory allergy immunotherapy," declares Nicolas Mouz, Chief Scientific Director at Protein'eXpert. "'This partnership offers us an opportunity to propose our expertise in protein engineering and therapeutic protein development, and to widen our knowledge of allergens."

About the "Enhanced Allergens" programme

The combination of molecular biology tools and of formulation/adjuvanting strategies makes it possible to target better the immune system of the sublingual mucous membrane, and to improve the efficacy of desensitisation treatments. It is on this major concept tha
'/>"/>

SOURCE Stallergenes
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
2. Stallergenes : 3rd Quarter Sales Up 17%: 9- Month Cumulative Sales Up 17%
3. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
4. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
5. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
6. When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell
7. When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell
8. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
9. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
10. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
11. Global Experts Explore Entire Spectrum of Aids Vaccine Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015  The Companion Diagnostics ... understanding and unprecedented access to the partnering deals ... healthcare companies during 2014. Using these ... into the partnering activities of the past year. ... the partnering and alliances deals announced worldwide.The initial ...
(Date:5/27/2015)... 27, 2015 RXi Pharmaceuticals Corporation (NASDAQ: ... discovering and developing innovative therapies primarily in the ... has commenced a public offering of shares of ... its common stock and overallotment purchase rights to ... of common stock, warrants and overallotment purchase rights ...
(Date:5/27/2015)... , May 26, 2015 ... announced the addition of Jain PharmaBiotech,s new ... and Companies" to their offering. ... molecular diagnostics technologies that will play an ... health, pharmaceutical industry, forensics and biological warfare ...
(Date:5/27/2015)... , May 26, 2015 Research and ... the "Global Breast Cancer Monoclonal Antibodies Market ... Globally, Roche seems to dominate the breast ... Its block buster molecule, Herceptin has been able ... was found that breast cancer cells become recalcitrant ...
Breaking Biology Technology:Companion Diagnostics Deals and Alliances of 2014 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 3Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 2Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 3Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3
(Date:5/27/2015)... , May 27, 2015   ... medication safety systems and image documentation solutions ... of comprehensive, technologically-advanced automation solutions, is pleased ... integration. The Codonics® Safe Label System® (SLS), ... in conjunction with the Omnicell Anesthesia Workstation, ...
(Date:5/26/2015)... May 26, 2015 Research ... addition of the "Saudi Arabia Biometric Systems ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The biometric ... is projected to grow at over 22% ... is attributed to the surging demand for better ...
(Date:5/25/2015)... SYDNEY , May 25, 2015  Australia,s market ... inception stage, although 2014 saw the advent of several ... on 24 April 2015 is expected to ignite interest ... devices in Australia . This in ... the industry and drive new partnerships amongst vendors and ...
Breaking Biology News(10 mins):Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4
... Laboratory (NREL) recently recognized the professionals behind the ... its Intellectual Property & Technology Transfer Awards. ... spectrum of renewable energy and energy efficiency technologies ... with industry partners, the luncheon celebrated NREL,s commercialization ...
... 2013 /PRNewswire-iReach/ -- Glutathione is the body,s master ... a large variety of other toxins and insults. Debate over ... levels in cells and tissues has simmered for years. Now, ... is effective in increasing the body,s stores of this vital ...
... researchers at the University of Pittsburgh have discovered a ... the same approach that HIV uses to infect cells. ... be described in the June issue of the journal ... promising in the development of a potential treatment for ...
Cached Biology News:NREL staff recognized for breakthrough technologies 2Clinical Tests Demonstrate Long-Term Effectiveness of Oral Glutathione Supplements - Kyowa Study 2Clinical Tests Demonstrate Long-Term Effectiveness of Oral Glutathione Supplements - Kyowa Study 3Pitt discovery holds potential in destroying drug-resistant bacteria 2Pitt discovery holds potential in destroying drug-resistant bacteria 3
...
Verotoxin IIbeta (457)...
Thermo Labsystems offers a basic reader for 96-well microplates that is especially adapted for ELISA and other colorimetric assays....
... Universal Vacuum System UVS400 is a multi-tasking ... UVS400 combines a refrigerated vapor trap and ... single integrated unit. The easy-to-use, wide-mouth glass ... into single jar for easy disposal. The ...
Biology Products: